Clinical Trials
33 trialsHIST-RIC
Institut Paoli-Calmettes
Efficacy of Capecitabine With Adjuvant Radiotherapy in Treatment of Early Stages Breast Cancer (Retrospective Study).
Assiut University
EEBC
Peking Union Medical College Hospital
STARS
Trans Tasman Radiation Oncology Group
Vinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0)
Second Affiliated Hospital of Soochow University
One Week Adjuvant Radiotherapy for Breast Cancer
Sohag University
TONIC
The Netherlands Cancer Institute
Radiotherapy for Extracranial Oligometastatic Breast Cancer
ChineseAMS
Adjuvant Whole Breast Irradiation in Five Fractions Versus Fifteen Fractions in Early Breast Cancer
Sohag University
Hypofractionated Radiotherapy Concomitantly With Weekly Boost for Breast Cancer Patients Treated With Conservative Breast Surgery
Assiut University
OBSERB
Kyungpook National University Chilgok Hospital
IMPORT
Institute of Cancer Research, United Kingdom
Neoadjuvant Chemotherapy Followed by Radiotherapy Alone in Patients With Breast Cancer
Instituto do Cancer do Estado de São Paulo
Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the Heart
AHS Cancer Control Alberta
Conventional Versus Hypofractionated Radiotherapy in Node Positive Breast Cancer
Ain Shams University
Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer Patients
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Breast-Conserving Therapy in Patients With Triple-Negative Breast Cancer
Sun Yat-sen University
Study of Arimidex and Radiotherapy Sequencing
Fudan University
Combination Chemotherapy in Treating Women With Breast Cancer
National Cancer Institute (NCI)
Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer
National Cancer Institute (NCI)
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer
National Cancer Institute (NCI)
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
National Cancer Institute (NCI)
Radiation Therapy or Standard Therapy in Treating Women With Stage II Breast Cancer Who Have Undergone Mastectomy
National Cancer Institute (NCI)
Comparison of Four Different Treatment Regimens in Treating Women With Stage I Breast Cancer
National Cancer Institute (NCI)
Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer
National Cancer Institute (NCI)
Resource-sparing Post-mastectomy Radiotherapy in Breast Cancer
International Atomic Energy Agency
CONSET
Tata Memorial Hospital
Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery
National Cancer Institute (NCI)
Radiation Therapy With or Without Temozolomide in Treating Women With Brain Metastases and Breast Cancer
National Cancer Institute (NCI)
Combination Chemotherapy in Treating Women With Resected Breast Cancer
National Cancer Institute (NCI)
Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole
National Cancer Institute (NCI)
Partial Breast Radiation to the Lumpectomy Cavity With IMRT in Elderly Women
University of Vermont
Boost Use in Breast Conservation Radiotherapy
St George Hospital, Australia